Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yucheng Xue

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Materials Today. Bio|June 22, 2026
Corrigendum to "Dual-functional hydrogel platform suppresses M1 activation and stabilizes M2 macrophages in intervertebral disc degeneration" [Mater. Today Bio, 38 (2026), 103087]Yiwen Xu, Zijun Zhang, Zhenzhong Chen, et al.
Molecular Cancer|September 9, 2024
Phenotypic and spatial heterogeneity of CD8<sup>+</sup> tumour infiltrating lymphocytesYikan Sun, Eloy Yinwang, Shengdong Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 7, 2026
Hierarchical Targeting of TREM2<sup>+</sup> Myeloid Cells via Acid-Triggered OMVs Reprogram Immunosuppression and Suppress Osteolysis in Bone-Metastatic TNBCFanglu Chen, Yucheng Xue, Xiao Ma, et al.
Nature Communications|July 22, 2022
Imaging topological and correlated insulating states in twisted monolayer-bilayer grapheneSi-Yu Li, Zhengwen Wang, Yucheng Xue, et al.
ACS Nano|June 26, 2024
Local Gate Enhanced Correlated Phases in Twisted Monolayer-Bilayer GrapheneYingbo Wang, Zhengwen Wang, Lu Cao, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 8, 2024
ZIF-8-Encapsulated Pexidartinib Delivery via Targeted Peptide-Modified M1 Macrophages Attenuates MDSC-Mediated Immunosuppression in OsteosarcomaJiabao Dong, Xupeng Chai, Yucheng Xue, et al.
Frontiers in Oncology|October 4, 2021
Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis SurgeriesHaochen Mou, Zhan Wang, Wenkan Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 28, 2022
Remotely Temporal Scheduled Macrophage Phenotypic Transition Enables Optimized Immunomodulatory Bone RegenerationDonghua Huang, Kaicheng Xu, Xin Huang, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 16, 2023
KERS-Inspired Nanostructured Mineral Coatings Boost IFN-γ mRNA Therapeutic Index for Antitumor ImmunotherapyZhenxuan Shao, Liang Chen, Zengjie Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 9, 2022
Tumor Customized 2D Supramolecular Nanodiscs for Ultralong Tumor Retention and Precise Photothermal Therapy of Highly Heterogeneous CancersPeng Lin, Yucheng Xue, Xueluer Mu, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Materials Today. Bio|June 22, 2026
Corrigendum to "Dual-functional hydrogel platform suppresses M1 activation and stabilizes M2 macrophages in intervertebral disc degeneration" [Mater. Today Bio, 38 (2026), 103087]Yiwen Xu, Zijun Zhang, Zhenzhong Chen, et al.
Molecular Cancer|September 9, 2024
Phenotypic and spatial heterogeneity of CD8<sup>+</sup> tumour infiltrating lymphocytesYikan Sun, Eloy Yinwang, Shengdong Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 7, 2026
Hierarchical Targeting of TREM2<sup>+</sup> Myeloid Cells via Acid-Triggered OMVs Reprogram Immunosuppression and Suppress Osteolysis in Bone-Metastatic TNBCFanglu Chen, Yucheng Xue, Xiao Ma, et al.
Nature Communications|July 22, 2022
Imaging topological and correlated insulating states in twisted monolayer-bilayer grapheneSi-Yu Li, Zhengwen Wang, Yucheng Xue, et al.
ACS Nano|June 26, 2024
Local Gate Enhanced Correlated Phases in Twisted Monolayer-Bilayer GrapheneYingbo Wang, Zhengwen Wang, Lu Cao, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 8, 2024
ZIF-8-Encapsulated Pexidartinib Delivery via Targeted Peptide-Modified M1 Macrophages Attenuates MDSC-Mediated Immunosuppression in OsteosarcomaJiabao Dong, Xupeng Chai, Yucheng Xue, et al.
Frontiers in Oncology|October 4, 2021
Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis SurgeriesHaochen Mou, Zhan Wang, Wenkan Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 28, 2022
Remotely Temporal Scheduled Macrophage Phenotypic Transition Enables Optimized Immunomodulatory Bone RegenerationDonghua Huang, Kaicheng Xu, Xin Huang, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 16, 2023
KERS-Inspired Nanostructured Mineral Coatings Boost IFN-γ mRNA Therapeutic Index for Antitumor ImmunotherapyZhenxuan Shao, Liang Chen, Zengjie Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 9, 2022
Tumor Customized 2D Supramolecular Nanodiscs for Ultralong Tumor Retention and Precise Photothermal Therapy of Highly Heterogeneous CancersPeng Lin, Yucheng Xue, Xueluer Mu, et al.
Pageof 4